+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannabinol Market by Product Type, Packaging, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Cannabinol Market by Product Type, Packaging, End User, Distribution Channel, Application - Global Forecast to 2030- Product Image
Sale

Cannabinol Market by Product Type, Packaging, End User, Distribution Channel, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977985
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cannabinol Market grew from USD 9.57 billion in 2024 to USD 10.55 billion in 2025. It is expected to continue growing at a CAGR of 10.30%, reaching USD 17.24 billion by 2030.

Exploring Cannabinol’s Emergence and Market Relevance

Cannabinol (CBN) is emerging as a pivotal cannabinoid with unique therapeutic promise and market potential. As interest intensifies in wellness and alternative therapeutics, stakeholders from pharmaceutical innovators to consumer health brands are turning their attention to CBN’s distinct pharmacological profile. Unlike its more widely known counterparts, cannabinol features a milder psychoactive effect paired with purported benefits for sleep support, pain management, and stress relief. This evolving profile has positioned CBN as a complementary offering alongside other cannabinoids, unlocking novel pathways for research and commercialization.

In recent years, regulatory frameworks have begun to adapt, guided by mounting clinical studies and shifting public perception. Advances in extraction and formulation technologies now allow for purer CBN isolates and versatile delivery formats. Meanwhile, consumer awareness campaigns and endorsements by healthcare practitioners have further legitimized the compound’s value proposition. This introduction sets the stage for a deep exploration of transformative market shifts, trade policies, segmentation dynamics, regional variations, and strategic imperatives that will define cannabinol’s trajectory in the coming years.

Shifting Market Dynamics Reshaping Cannabinol Adoption

The cannabinol landscape is experiencing several converging shifts that promise to redefine its competitive contours. Regulatory bodies in key markets have begun to differentiate CBN from other cannabinoids, thereby streamlining approval pathways for research and product launch. Simultaneously, pharmaceutical and nutraceutical firms are forging partnerships to harness specialized extraction processes, enhancing purity and consistency at scale. This collaboration between science and industry is generating a virtuous cycle of innovation and validation.

Consumer demand is also undergoing a transformation as end users seek targeted wellness solutions. The narrative has shifted from broadly defined cannabis products to precision-engineered formulations addressing specific health concerns. Technological breakthroughs-ranging from nanoemulsion to transdermal patch delivery-are increasing bioavailability and consumer convenience. In parallel, digital health platforms and telemedicine services are integrating CBN into holistic care pathways, amplifying its reach through evidence-based protocols. Consequently, the cannabinol market is evolving from a niche curiosity into a structured sector with clear regulatory, scientific, and commercial roadmaps.

Assessing the 2025 U.S. Tariffs’ Ripple Effect on Cannabinol

The introduction of new tariff schedules in the United States for 2025 has exerted a pronounced influence on cannabinol trade flows. Import duties on hemp extracts and isolates have led many international suppliers to reassess their cost structures, prompting a migration of production investments toward domestic facilities. This reshoring trend addresses tariff pressures while aligning with growing demand for locally sourced, high-purity cannabinoids.

Price sensitivity among institutional buyers and contract manufacturers has intensified, driving negotiations over supply agreements and quality assurances. Some exporters have opted to absorb part of the tariff burden, leveraging economies of scale to retain US market access. Others have pivoted to markets with more favorable trade terms, redistributing volumes to balance revenue impacts. Meanwhile, policymakers are evaluating the broader economic implications, with industry advocacy groups pressing for adjustments to support supply chain resilience. Ultimately, these tariff measures are catalyzing a recalibration of sourcing strategies, fostering investments in domestic extraction capacity and stimulating innovation in cost-effective purification technologies.

Decoding Cannabinol Market Segmentation Drivers and Trends

Market segmentation reveals nuanced opportunities across product, packaging, end user, channel, and application dimensions. When examining product type segmentation, the market divides into capsules, distillates, isolates, tinctures, and topicals, with balms, creams, and salves forming a further subcategory within topicals. These varied delivery formats cater to different consumer preferences, whether for discreet dosing, rapid onset, or skin-targeted relief. Packaging segmentation underscores the importance of user experience and compliance, with blister packs offering pre-measured consistency, bottles providing familiar convenience, and pouches catering to on-the-go consumption.

End user segmentation highlights the distinct requirements of healthcare providers, research institutions, and retail consumers-of whom adults demonstrate strong interest in stress and sleep support, while seniors prioritize pain management. Distribution channels range from direct sales agreements with clinical partners to robust online retail platforms and brick-and-mortar physical stores, the latter comprising specialized health food outlets and traditional pharmacies. Each channel demands tailored marketing, education, and logistical frameworks. Application segmentation underscores therapeutic demand for anxiety and stress management, appetite stimulation, chronic pain relief, and sleep disorder interventions, with insomnia and parasomnia treatments emerging as the most researched subcategories. By integrating these segmentation lenses, stakeholders can align product development, regulatory strategy, and go-to-market initiatives with the highest-value market niches.

Uncovering Regional Disparities and Opportunities in CBN Markets

Regional insights illuminate divergent growth trajectories and strategic imperatives. In the Americas, mature wellness markets in North America drive demand for high-purity CBN extracts backed by clinical validation, while Latin America presents untapped potential thanks to regulatory liberalization and burgeoning hemp cultivation. Market participants in the United States and Canada are advancing brand differentiation through premium formulations and rigorous third-party testing protocols.

The Europe, Middle East & Africa landscape is characterized by heterogeneous regulations and a mosaic of market maturity. Western European nations lead with standardized product frameworks and reimbursement discussions, whereas emerging economies in Eastern Europe and the Middle East are exploring pilot programs for medical applications. Africa’s nascent market is gaining traction through industrial hemp initiatives, with CBN research clusters forming around academic institutions in South Africa and Morocco.

In the Asia-Pacific region, regulatory reform in Australia and New Zealand has opened commercial pathways for CBN-infused wellness products, backed by progressive clinical research. Meanwhile, markets in China, Japan, and South Korea emphasize stringent quality standards and GMP compliance, driving investments in high-technology extraction facilities. Southeast Asian nations are evaluating policy shifts to incorporate cannabinol into national health strategies, signaling future growth hotspots.

Profiling Leading Innovators Driving the Cannabinol Industry Forward

Industry leaders are differentiating through targeted research, strategic partnerships, and vertical integration. Major agritech and pharmaceutical firms have secured intellectual property portfolios around novel CBN derivatives, while established cannabis producers are leveraging existing cultivation and extraction capabilities to introduce proprietary CBN formulations. Biotechnology startups are emerging with innovative biosynthesis approaches, promising scalable and cost-effective pathways to high-purity cannabinol.

Cross-sector collaborations are also proliferating, as contract research organizations join forces with nutraceutical brands to accelerate clinical trials. Packaging and logistics companies specializing in cold-chain management are entering the ecosystem to address stability challenges. Simultaneously, digital health platforms are integrating CBN analytics tools, providing end users with personalized dosing recommendations. These complementary strategies reveal a vibrant competitive landscape where agility, scientific credibility, and integrated supply chains determine market leadership.

Strategic Imperatives for CBN Industry Leaders to Capitalize on Growth

Industry leaders should prioritize investments in advanced R&D to refine extraction techniques and enhance bioavailability, thereby differentiating their offerings and justifying premium pricing. Elevating quality assurance through standardized testing protocols and transparent traceability systems will build stakeholder trust and streamline regulatory approvals. Collaborative alliances between clinical research centers and commercial entities can accelerate data generation, strengthening the evidence base for new applications.

Furthermore, companies must adopt omnichannel engagement strategies that blend direct partnerships with healthcare providers and research institutions alongside consumer-facing digital platforms. Tailored educational campaigns and thought leadership content will guide end users through CBN’s unique benefits. Supply chain resilience can be fortified by diversifying sourcing footprints and leveraging domestic extraction capacity. Finally, embracing sustainability practices-from green extraction solvents to eco-friendly packaging-will resonate with increasingly conscious consumers and support long-term brand equity.

Robust Research Framework Underpinning Cannabinol Market Insights

This analysis is grounded in a robust two-phase research methodology integrating secondary and primary approaches. The secondary phase included rigorous reviews of peer-reviewed journals, government and regulatory publications, industry white papers, and market intelligence databases to map historical and contemporaneous industry dynamics. These sources provided a foundational understanding of pharmacological research, legal frameworks, and pioneering product developments.

The primary phase involved in-depth interviews with senior executives at cultivation operations, extraction laboratories, contract manufacturers, healthcare practitioners, and distribution partners to validate hypotheses and uncover emerging trends. Data triangulation was employed to reconcile discrepancies and ensure analytical rigor. Segmentation analyses were conducted using qualitative insights and quantitative data, while expert panel discussions with academic and industry authorities provided critical peer review. This systematic framework underpins the credibility and precision of the insights presented herein.

Concluding Perspectives on the Future Trajectory of Cannabinol

Cannabinol is poised to revolutionize the cannabinoid industry through its differentiated therapeutic potential and evolving regulatory acceptance. The market’s transformative shifts-driven by policy reforms, scientific breakthroughs, and consumer sophistication-are creating a structured environment for sustained growth. Navigating the implications of 2025 U.S. tariff adjustments will require agile sourcing strategies and strategic domestic investments.

By leveraging granular segmentation and regional insights, companies can tailor product portfolios and go-to-market strategies to high-value niches. Leading firms are already establishing competitive moats through proprietary extraction technologies, strategic alliances, and integrated supply chains. The path forward demands collaborative innovation, rigorous quality standards, and proactive engagement with regulators and end users. Armed with a deep understanding of these dynamics, stakeholders are well positioned to harness cannabinol’s full market potential.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Capsules
    • Distillates
    • Isolates
    • Tinctures
    • Topicals
      • Balms
      • Creams
      • Salves
  • Packaging
    • Blister Packs
    • Bottles
    • Pouches
  • End User
    • Healthcare Providers
    • Research Institutions
    • Retail Consumers
      • Adults
      • Seniors
  • Distribution Channel
    • Direct Sales
    • Online Retail
    • Physical Stores
      • Health Food Stores
      • Pharmacies
  • Application
    • Anxiety and Stress Management
    • Appetite Stimulation
    • Chronic Pain Relief
    • Sleep Disorders
      • Insomnia
      • Parasomnia
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • AURORA CANNABIS INC.
  • CHARLOTTE’S WEB, INC.
  • CV Sciences, Inc.
  • Diamond CBD
  • Elixinol Wellness Limited
  • ENDOCA.
  • Etz Hayim Holdings, SPC
  • Folium Biosciences Europe B.V.
  • Fresh Bros Hemp Company
  • Gaia Herbs, Inc.
  • Green Roads
  • GVB Biopharma
  • High Labs International Inc.
  • Isodiol International Inc.
  • KND Labs
  • Medical Marijuana, Inc.
  • Medterra CBD, LLC
  • NuLeaf Naturals, LLC
  • Pharma Works LLC
  • PharmaHemp d.o.o.
  • Red Mesa Science & Refining, LLC
  • Shaman Botanicals LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cannabinol Market, by Product Type
8.1. Introduction
8.2. Capsules
8.3. Distillates
8.4. Isolates
8.5. Tinctures
8.6. Topicals
8.6.1. Balms
8.6.2. Creams
8.6.3. Salves
9. Cannabinol Market, by Packaging
9.1. Introduction
9.2. Blister Packs
9.3. Bottles
9.4. Pouches
10. Cannabinol Market, by End User
10.1. Introduction
10.2. Healthcare Providers
10.3. Research Institutions
10.4. Retail Consumers
10.4.1. Adults
10.4.2. Seniors
11. Cannabinol Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Online Retail
11.4. Physical Stores
11.4.1. Health Food Stores
11.4.2. Pharmacies
12. Cannabinol Market, by Application
12.1. Introduction
12.2. Anxiety and Stress Management
12.3. Appetite Stimulation
12.4. Chronic Pain Relief
12.5. Sleep Disorders
12.5.1. Insomnia
12.5.2. Parasomnia
13. Americas Cannabinol Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cannabinol Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cannabinol Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AURORA CANNABIS INC.
16.3.2. CHARLOTTE’S WEB, INC.
16.3.3. CV Sciences, Inc.
16.3.4. Diamond CBD
16.3.5. Elixinol Wellness Limited
16.3.6. ENDOCA.
16.3.7. Etz Hayim Holdings, SPC
16.3.8. Folium Biosciences Europe B.V.
16.3.9. Fresh Bros Hemp Company
16.3.10. Gaia Herbs, Inc.
16.3.11. Green Roads
16.3.12. GVB Biopharma
16.3.13. High Labs International Inc.
16.3.14. Isodiol International Inc.
16.3.15. KND Labs
16.3.16. Medical Marijuana, Inc.
16.3.17. Medterra CBD, LLC
16.3.18. NuLeaf Naturals, LLC
16.3.19. Pharma Works LLC
16.3.20. PharmaHemp d.o.o.
16.3.21. Red Mesa Science & Refining, LLC
16.3.22. Shaman Botanicals LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CANNABINOL MARKET MULTI-CURRENCY
FIGURE 2. CANNABINOL MARKET MULTI-LANGUAGE
FIGURE 3. CANNABINOL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANNABINOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANNABINOL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANNABINOL MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANNABINOL MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANNABINOL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANNABINOL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANNABINOL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANNABINOL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANNABINOL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANNABINOL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANNABINOL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANNABINOL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANNABINOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANNABINOL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANNABINOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANNABINOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANNABINOL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANNABINOL MARKET SIZE, BY DISTILLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANNABINOL MARKET SIZE, BY ISOLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANNABINOL MARKET SIZE, BY TINCTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANNABINOL MARKET SIZE, BY TOPICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANNABINOL MARKET SIZE, BY BALMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANNABINOL MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANNABINOL MARKET SIZE, BY SALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANNABINOL MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANNABINOL MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANNABINOL MARKET SIZE, BY POUCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANNABINOL MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANNABINOL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANNABINOL MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANNABINOL MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANNABINOL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANNABINOL MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANNABINOL MARKET SIZE, BY PHYSICAL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANNABINOL MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANNABINOL MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANNABINOL MARKET SIZE, BY ANXIETY AND STRESS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANNABINOL MARKET SIZE, BY APPETITE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANNABINOL MARKET SIZE, BY CHRONIC PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANNABINOL MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANNABINOL MARKET SIZE, BY PARASOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CANNABINOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANNABINOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 64. CANADA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 65. CANADA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 67. CANADA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. CANADA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 69. CANADA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CANNABINOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 117. GERMANY CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 119. GERMANY CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 120. GERMANY CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 129. FRANCE CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. FRANCE CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 144. ITALY CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. ITALY CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 146. ITALY CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 147. ITALY CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ITALY CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 149. ITALY CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. ITALY CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 151. ITALY CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. ITALY CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 153. SPAIN CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SPAIN CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 155. SPAIN CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 156. SPAIN CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SPAIN CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 158. SPAIN CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SPAIN CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 160. SPAIN CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. DENMARK CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 192. DENMARK CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. DENMARK CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 194. DENMARK CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. DENMARK CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 196. DENMARK CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. DENMARK CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 207. QATAR CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. QATAR CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 209. QATAR CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 210. QATAR CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. QATAR CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 212. QATAR CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. QATAR CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 214. QATAR CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. QATAR CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 216. FINLAND CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 219. FINLAND CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. FINLAND CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 246. EGYPT CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. EGYPT CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 248. EGYPT CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. EGYPT CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 250. EGYPT CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. EGYPT CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 252. TURKEY CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. TURKEY CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 254. TURKEY CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 255. TURKEY CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. TURKEY CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 257. TURKEY CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. TURKEY CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 270. NORWAY CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 273. NORWAY CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. NORWAY CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 275. NORWAY CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. NORWAY CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 279. POLAND CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. POLAND CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 281. POLAND CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 282. POLAND CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. POLAND CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 284. POLAND CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. POLAND CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 286. POLAND CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC CANNABINOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 307. CHINA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. CHINA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 309. CHINA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 310. CHINA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. CHINA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 312. CHINA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. CHINA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 314. CHINA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. CHINA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 316. INDIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 318. INDIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 319. INDIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. INDIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 321. INDIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. INDIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 323. INDIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. INDIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 325. JAPAN CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. JAPAN CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 328. JAPAN CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. JAPAN CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 330. JAPAN CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 331. JAPAN CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 332. JAPAN CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. JAPAN CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 361. THAILAND CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 362. THAILAND CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 363. THAILAND CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 364. THAILAND CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 365. THAILAND CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 366. THAILAND CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 367. THAILAND CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 368. THAILAND CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 369. THAILAND CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 370. PHILIPPINES CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 371. PHILIPPINES CANNABINOL MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 372. PHILIPPINES CANNABINOL MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 373. PHILIPPINES CANNABINOL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 374. PHILIPPINES CANNABINOL MARKET SIZE, BY RETAIL CONSUMERS, 2018-2030 (USD MILLION)
TABLE 375. PHILIPPINES CANNABINOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 376. PHILIPPINES CANNABINOL MARKET SIZE, BY PHYSICAL STORES, 2018-2030 (USD MILLION)
TABLE 377. PHILIPPINES CANNABINOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 378. PHILIPPINES CANNABINOL MARKET SIZE, BY SLEEP DISORDERS, 2018-2030 (USD MILLION)
TABLE 379. MALAYSIA CANNABINOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 380. MALAYSIA CANNABINOL MARKET SIZE, BY TOPICALS, 2018-20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cannabinol market report include:
  • AURORA CANNABIS INC.
  • CHARLOTTE’S WEB, INC.
  • CV Sciences, Inc.
  • Diamond CBD
  • Elixinol Wellness Limited
  • ENDOCA.
  • Etz Hayim Holdings, SPC
  • Folium Biosciences Europe B.V.
  • Fresh Bros Hemp Company
  • Gaia Herbs, Inc.
  • Green Roads
  • GVB Biopharma
  • High Labs International Inc.
  • Isodiol International Inc.
  • KND Labs
  • Medical Marijuana, Inc.
  • Medterra CBD, LLC
  • NuLeaf Naturals, LLC
  • Pharma Works LLC
  • PharmaHemp d.o.o.
  • Red Mesa Science & Refining, LLC
  • Shaman Botanicals LLC

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.55 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.24 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Cannabinol (CAS 521-35-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cannabinol (CAS 521-35-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Cannabis Capsule Market Report 2025 - Product Image

Cannabis Capsule Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cannabinoids Market Report 2025 - Product Image

Cannabinoids Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Medical Marijuana - Cannabidiol - Pipeline Insight, 2025 - Product Image

Medical Marijuana - Cannabidiol - Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Minor Cannabinoids Market by Product Type, Application, Form, Distribution Channel, End Use Industry, Extraction Method - Global Forecast to 2030 - Product Image

Minor Cannabinoids Market by Product Type, Application, Form, Distribution Channel, End Use Industry, Extraction Method - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From

About the Cannabinol Market

Cannabinol (CBN) is a naturally occurring cannabinoid found in the cannabis plant. It is known to have analgesic properties, which makes it a potential therapeutic option for pain relief. CBN has been studied for its potential to reduce inflammation and act as an anti-inflammatory agent. It has also been studied for its potential to reduce anxiety and depression. CBN is gaining traction in the analgesic market due to its potential to provide relief from pain without the psychoactive effects of THC. It is being studied for its potential to treat a variety of conditions, including chronic pain, arthritis, and fibromyalgia. The CBN market is growing rapidly, with more companies entering the space and offering products containing CBN. Companies such as Charlotte's Web, Elixinol, and Endoca are leading the way in the CBN market, offering products such as tinctures, capsules, and topical creams. Other companies such as Kannaway and PlusCBD are also offering CBN products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.